Cape Investment Advisory, Inc.

Position in OGN — Organon & Co.

CIK 1944437 MCDONOUGH, GA

Position in OGN

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$2,572

+$1,777 QoQ

Shares Held

190

+71.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#403

of 626 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Cape Investment Advisory, Inc. holds $3,326,940 across 15 Drug Manufacturers - General names. OGN ranks #14 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	2,880	$731,432
2	LLY	ELI LILLY & Co	464	$556,535
3	GSK	GSK plc	9,228	$483,731
4	ABBV	AbbVie Inc.	1,417	$356,573
5	MRK	Merck & Co., Inc.	2,665	$342,452
6	PFE	Pfizer Inc	12,694	$305,671
7	AMGN	Amgen Inc	631	$228,497
8	NVS	Novartis AG	747	$117,069

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,572	190	+71.2%	Shares	Sole	2026-07-23
2025-12-31	$795	111	+152.3%	Shares	Sole	2026-02-17
2025-09-30	$469	44	-66.2%	Shares	Sole	2025-12-29
2025-06-30	$1,258	130	0.0%	Shares	Sole	2025-08-19
2025-03-31	$1,935	130	0.0%	Shares	Sole	2025-05-16
2024-12-31	$1,939	130	+51.2%	Shares	Sole	2025-02-05
2024-09-30	$1,645	86	0.0%	Shares	Sole	2024-11-14
2024-06-30	$1,780	86	0.0%	Shares	Sole	2024-08-15
2024-03-31	$1,616	86	-44.9%	Shares	Defined	2024-06-21
2023-12-31	$2,249	156	+4.7%	Shares	Sole	2024-02-12
2023-09-30	$2,586	149	-18.1%	Shares	Defined	2023-11-07
2023-06-30	$3,787	182	-13.7%	Shares	Sole	2023-10-12
2023-03-31	$4,962	211	—	Shares	Sole	2023-10-12
No filing history on record for this holder in this stock.